Full Text View
Tabular View
Study Results
Related Studies
Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy Participants
This study has been completed.
Study NCT01068717   Information provided by AstraZeneca

First Received on February 12, 2010.   Last Updated on June 4, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial